References
- Ali MA, Shaharyar M, De Clercq E. Synthesis of 5-(4-hydroxy-3-methylphenyl)-5-(substituted phenyl)-4,5-dihydro-1H-1-pyrazolyl-4-pyridylmethanone derivatives with anti-viral activity. J Enz Inhib Med Chem 2007; 22: 702–708.
- Shaharyar M, Siddiqui AA, Ali MA, Murugan V, Raghu C. Synthesis and Cytotoxic activity of novel pyrazoline derivatives against human lung tumor cell line. J Chin Chem Soc 2007; 54: 81–86.
- Ali MA, Shaharyar M. Antitubercular activity of novel substituted 4,5-dihydro-1H-1-pyrazolylmethanethiones. J Enz Inhib Med Chem 2007; 22: 183–189.
- Shaharyar M, Siddiqui AA, Ali MA, Sriram D, Yogeshwari P. Synthesis and in-vitro antimycobacterial activity of N1- nicotinoyl-3-(4_-hydroxy-3_-methylphenyl )-5-[( sub) phenyl]-2-pyrazolines. Bioorg Med Chem Lett 2006; 16: 3947–3949.
- Rajendra Prasad Y, Lakshmana Rao A, Prasoona L, Murali K, Ravi Kumar P. Synthesis and antidepressant activity of some 1,3,5-triphenyl-2-pyrazolines and 3-(2”-hydroxynaphthalen-1”-yl)-1,5-diphenyl-2-pyrazolines. Bioorg Med Chem Lett 2005; 15: 5030–5034.
- Kucukguzel SG, Rollas S. Synthesis, characterization of novel coupling products and 4-arylhydrazono-2-pyrazoline-5-ones as potential antimycobacterial agents. Farmaco 2002; 57: 583–587.
- Bekhit AA, Ashour HMA, Guemei AA. Novel pyrazole derivatives as potential promising anti-inflammatory antimicrobial agents. Arch Pharm (Weinheim) 2005; 338: 167–174.
- Turan-Zitouni G, Ozdemir A, Guven K. Synthesis of some 1-[(N,N-disubstituted thiocarbamoylthio)acetyl]-3-(2-thienyl)-5-aryl-2-pyrazoline derivatives and investigation of their antibacterial and antifungal activities. Arch Pharm (Weinheim) 2005; 338: 96–104.
- Ruhoglu O, Ozdemir Z, Calis U, Gumusel B, Bilgin AA. Synthesis of and pharmacological studies on the antidepressant and anticonvulsant activities of some 1,3,5-trisubstituted pyrazolines. Arzneimittel-Forschung 2005; 55: 431–436.
- Ucar G, Gokhan N, Yesilada A, Bilgin AA. 1-N-Substituted thiocarbamoyl-3-phenyl-5-thienyl-2-pyrazolines: a novel cholinesterase and selective monoamine oxidase B inhibitors for the treatment of Parkinson’s and Alzheimer’s diseases. Neurosci Lett 2005; 15: 327–331.
- Amr AE., Abdel-Latif NA, Abdalla MM. Synthesis and antiandrogenic activity of some new 3-substituted androstano-[17,16-c]-5’-aryl-pyrazoline and their derivatives. Bioorg Med Chem 2006; 14: 373–384.
- De Clercq E, Holý A, Rosenberg I, Sakuma T, Balzarini J, Maudgal PC. A novel selective broad-spectrum anti-DNA virus agent. Nature 1986; 323: 464–467.
- Pauwels R, Balzarini J, Baba M, Snoeck R, Schols D, Herdewijn P, Desmyter J. Rapid and automated tetrazoliumbased colorimetric assay for the detection of anti-HIV compounds. J Virol Meth 1988; 20: 309–321.
- De Clercq E. Antiviral and antimetabolic activities of neplanocins. Antimicrob Agents Chemother 1985; 28: 84–89.